I am seeing messages that this latest drug was approved. BUT BUT I do not know for certain. Trading has been halted for quite awhile and bid is not at 6.01 and ask is at 6.30. waiting for the halt to end
Recent ARDX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:05:05 PM
- Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings • GlobeNewswire Inc. • 04/27/2026 12:01:00 PM
- Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 • GlobeNewswire Inc. • 04/23/2026 12:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 08:04:27 PM
- Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026 • GlobeNewswire Inc. • 04/16/2026 12:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:16:22 PM
- Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx • GlobeNewswire Inc. • 04/01/2026 12:01:00 PM
- Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Ardelyx to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:47:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:45:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 01:45:03 AM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/23/2026 11:17:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2026 12:18:49 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:57:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:35:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:21:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 11:07:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 10:48:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2026 10:18:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:03:51 PM
- Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/19/2026 09:01:00 PM
